Background

• Clinically -integrated health system specialty pharmacies are uniquely positioned to track the reason for a patient’s discontinuation of therapy.
• It is understood that common reasons patients discontinue therapy include ineffectiveness, adverse events, and managed care formulary restrictions. This real-world data can be used to better predict which therapies are likely to result in better adherence for individual patients.

Objectives

Because discontinuation rates vary by disease state, the primary objective of this study is to analyze the reasons for these discontinuations and develop targeted interventions that are specific to their respective drug and disease state to avoid unwarranted discontinuation.

Read the Outcomes Study by submitting the form below.

​